Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Revenues:
Net product sales	$ 32,810	$ 31,434	$ 103,504	$ 92,811
Cost of product sales	9,458	18,208	28,420	55,220
Gross profit	23,352	13,226	75,084	37,591
Operating expenses:
Research and development	4,465	9,285	13,505	31,331
General and administrative	12,373	15,914	41,252	51,340
Sales and marketing	10,972	12,956	36,028	55,315
Total operating expenses	27,810	38,155	90,785	137,986
Loss from operations	(4,458)	(24,929)	(15,701)	(100,395)
Other (expense) income, net	(390)	(79)	(1,542)	560
Net loss	(4,848)	(25,008)	(17,243)	(99,835)
Other comprehensive income:
Unrealized gains on short-term investments	48	5	27	18
Comprehensive loss	$ (4,800)	$ (25,003)	$ (17,216)	$ (99,817)
Basic net loss per common share	$ (0.03)	$ (0.17)	$ (0.11)	$ (0.75)
Weighted average common shares outstanding, basic	152,830	144,990	152,213	133,747
Diluted net loss per common share	$ (0.03)	$ (0.17)	$ (0.11)	$ (0.75)
Weighted average common shares outstanding, diluted	152,830	144,990	152,213	133,747